Anti-Fibrotic Effects of Pirfenidone and Rapamycin in Primary IPF Fibroblasts and Human Alveolar Epithelial Cells
BMC Pulmonary Medicine - United Kingdom
doi 10.1186/s12890-018-0626-4
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2018
Authors
Publisher
Springer Science and Business Media LLC